Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Locally Advanced HER2-negative Breast Cancer
Interventions: DRUG: Paclitaxel/doxorubicin/cyclophosphamide|DRUG: Paclitaxel/doxorubicin/cyclophosphamide
Sponsor: Instituto do Cancer do Estado de São Paulo
Collaborators: Fundação Faculdade de Medicina